Bullseye Asset Management LLC Decreases Stake in Phreesia, Inc. (NYSE:PHR)

by · The Cerbat Gem

Bullseye Asset Management LLC decreased its holdings in shares of Phreesia, Inc. (NYSE:PHR – Free Report) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 99,002 shares of the company’s stock after selling 1,261 shares during the quarter. Bullseye Asset Management LLC owned about 0.17% of Phreesia worth $2,491,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. boosted its position in shares of Phreesia by 10.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company’s stock valued at $12,415,000 after acquiring an additional 46,209 shares during the last quarter. Wesbanco Bank Inc. boosted its holdings in Phreesia by 76.9% in the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after purchasing an additional 20,000 shares during the last quarter. Barclays PLC grew its stake in shares of Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after buying an additional 43,225 shares during the period. Franklin Resources Inc. grew its stake in shares of Phreesia by 3.0% in the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after buying an additional 42,973 shares during the period. Finally, Geode Capital Management LLC increased its holdings in shares of Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after buying an additional 55,934 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Stock Up 1.7 %

Phreesia stock opened at $24.59 on Friday. The firm has a market capitalization of $1.45 billion, a P/E ratio of -16.73 and a beta of 0.82. The stock’s fifty day simple moving average is $25.62 and its 200-day simple moving average is $24.34. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Insiders Place Their Bets

In other news, CFO Balaji Gandhi sold 4,813 shares of the firm’s stock in a transaction on Monday, January 27th. The shares were sold at an average price of $27.48, for a total value of $132,261.24. Following the sale, the chief financial officer now directly owns 144,933 shares in the company, valued at approximately $3,982,758.84. This trade represents a 3.21 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 6,556 shares of the business’s stock in a transaction on Monday, January 27th. The stock was sold at an average price of $27.48, for a total transaction of $180,158.88. Following the transaction, the general counsel now owns 152,361 shares of the company’s stock, valued at approximately $4,186,880.28. The trade was a 4.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 146,930 shares of company stock worth $4,067,102 in the last quarter. 5.80% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on PHR shares. DA Davidson cut their target price on Phreesia from $36.00 to $34.00 and set a “buy” rating for the company in a research note on Monday, April 14th. Citigroup raised their price objective on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Canaccord Genuity Group upped their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research report on Thursday, March 13th. KeyCorp dropped their price target on shares of Phreesia from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Wednesday, April 16th. Finally, Needham & Company LLC restated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Thursday, March 13th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $31.33.

Read Our Latest Analysis on PHR

About Phreesia

(Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

Further Reading